These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ocular manifestations of nephropathic cystinosis. The French-Canadian experience in a genetically homogeneous population. Richler M; Milot J; Quigley M; O'Regan S Arch Ophthalmol; 1991 Mar; 109(3):359-62. PubMed ID: 2003795 [TBL] [Abstract][Full Text] [Related]
3. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis. Kalatzis V; Serratrice N; Hippert C; Payet O; Arndt C; Cazevieille C; Maurice T; Hamel C; Malecaze F; Antignac C; Müller A; Kremer EJ Pediatr Res; 2007 Aug; 62(2):156-62. PubMed ID: 17597652 [TBL] [Abstract][Full Text] [Related]
5. NIH conference. Cystinosis: progress in a prototypic disease. Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161 [TBL] [Abstract][Full Text] [Related]
6. Complications of nephropathic cystinosis after renal failure. Gahl WA; Kaiser-Kupfer MI Pediatr Nephrol; 1987 Jul; 1(3):260-8. PubMed ID: 3153286 [TBL] [Abstract][Full Text] [Related]
7. Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine. Dureau P; Broyer M; Dufier JL J Pediatr Ophthalmol Strabismus; 2003; 40(3):142-6. PubMed ID: 12795432 [TBL] [Abstract][Full Text] [Related]
8. The effect of topical cysteamine drops on reducing crystal formation within the cornea of patients affected by nephropathic cystinosis. MacDonald IM; Noel LP; Mintsioulis G; Clarke WN J Pediatr Ophthalmol Strabismus; 1990; 27(5):272-4. PubMed ID: 2246744 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy. Tavares R; Coelho D; Macário MC; Torres A; Quadrado MJ; Murta J Cornea; 2009 Sep; 28(8):938-40. PubMed ID: 19654516 [TBL] [Abstract][Full Text] [Related]
13. Follow-up and treatment of adults with cystinosis in the Netherlands. Geelen JM; Monnens LA; Levtchenko EN Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982 [TBL] [Abstract][Full Text] [Related]
14. Classic nephropathic cystinosis as an adult disease. Theodoropoulos DS; Krasnewich D; Kaiser-Kupfer MI; Gahl WA JAMA; 1993 Nov; 270(18):2200-4. PubMed ID: 8411603 [TBL] [Abstract][Full Text] [Related]
15. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Gahl WA; Balog JZ; Kleta R Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758 [TBL] [Abstract][Full Text] [Related]
16. Corneal sensitivity in nephropathic cystinosis. Katz B; Melles RB; Schneider JA Am J Ophthalmol; 1987 Oct; 104(4):413-6. PubMed ID: 3661652 [TBL] [Abstract][Full Text] [Related]
17. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis. Wühl E; Haffner D; Gretz N; Offner G; van't Hoff WG; Broyer M; Mehls O Pediatr Res; 1998 Apr; 43(4 Pt 1):484-8. PubMed ID: 9545002 [TBL] [Abstract][Full Text] [Related]
18. [Cystinosis: an infrequent cause of distal myopathy]. Rodríguez-Gómez FJ; López-Domínguez JM; Borrero-Martín JJ; Rodríguez-Gómez E; Chinchón-Lara I; Pujol-De la Llave E Rev Neurol; 2005 Feb 1-15; 40(3):156-8. PubMed ID: 15750900 [TBL] [Abstract][Full Text] [Related]